Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
19 participants
OBSERVATIONAL
2012-03-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wheezometer™ Exploratory (WM) Field Study
NCT01156818
Self Operating of the Personal WheezoMeter by Intended Users - A Usability Study
NCT00901433
vDOT for Newly Diagnosed Pediatric Asthma
NCT05120323
Personalised Outcomes in Children With Recurrent Wheeze
NCT03858010
Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
NCT00395096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Wheezing - age 5-12
No interventions assigned to this group
Active Wheezing - under age 5
No interventions assigned to this group
No Wheezing
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Control:
* Patients \<= 12 years of age without history of asthma or other pulmonary conditions, and who are without wheezing on physical exam.
Exclusion Criteria
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iSonea
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 1
Folsom, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iS-2012-Wz
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.